There’s still scope for a new generation of drugs to replace weight-loss market leaders like Novo Nordisk A/S’s Wegovy, ...

We meet some of the first NHS patients, as expert says funding everyone eligible would "bankrupt" the service.

The Biden administration is expected to release the next batch of drugs that will be subject to Medicare price negotiations — ...

A new review highlights the future of anti-obesity medications that could outperform today's already blockbuster drugs like ...

The round is one of Europe’s largest-ever biotech VC deals, signalling investor appetite for the booming weight loss market.

GlobalData has named heart failure as the next disease to feel the sales-boosting power of GLP-1 drugs. The analysts expect ...

New tests may show how much value a particular obese patient will get for a GLP-1 agonist prescription dollar.

A range of GLP-1 weight loss drugs are currently on the market. What are they, what do they do, and where are they available?

In a recent episode of the global health and wellness show Bloom, host Gayle Guyardo welcomed Dr. Bharti Shetye, MD, MFOMA, a ...

Polls provide a useful window into understanding how Americans view their own weight and the recent availability of drugs ...

President-elect Donald Trump’s quest to buy Greenland from Denmark could make Ozempic and Wegovy, the weight-loss and ...